{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T04:26:01Z","timestamp":1777695961729,"version":"3.51.4"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8,1]]},"abstract":"<jats:sec><jats:title>OBJECTIVE:<\/jats:title><jats:p>To describe the use of inhaled nitric oxide (INO) in newborns with congenital diaphragmatic hernia (CDH).<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>Pediatric Health Information System data were queried for newborns with CDH admitted at &amp;lt;8 days of age at tertiary care US pediatric hospitals between 2003 and 2011. INO treatment status and timing in relation to CDH repair were determined for each infant. Hospital-specific rates of INO use, extracorporeal membrane oxygenation (ECMO) use, and mortality were determined.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Data were analyzed for 1713 neonates with CDH admitted to 33 hospitals. More than half (57%) received INO during their inpatient stay, and utilization varied dramatically between hospitals (34% to 92%). Neonates treated with INO accumulated &amp;gt;$81 million in pharmacy charges. The proportion of infants receiving INO as well as their duration of therapy increased significantly during the study period. The rate of ECMO utilization and mortality did not change significantly during the study period. Hospital-specific mortality rates did not correlate with INO therapy, ECMO utilization, or case volume.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>INO use in neonates with CDH is widespread, and has increased at many US tertiary pediatric hospitals without contemporaneous change in ECMO utilization or mortality. The improvement of evidence-based guidelines for the use of INO in newborns with CDH could lead to a reduction in health care costs for these patients.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.2013-2644","type":"journal-article","created":{"date-parts":[[2014,7,15]],"date-time":"2014-07-15T02:14:47Z","timestamp":1405390487000},"page":"e420-e426","source":"Crossref","is-referenced-by-count":68,"title":["Inhaled Nitric Oxide Use in Neonates With Congenital Diaphragmatic Hernia"],"prefix":"10.1542","volume":"134","author":[{"given":"Brendan T.","family":"Campbell","sequence":"first","affiliation":[{"name":"Departments of Pediatric Surgery, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine W.","family":"Herbst","sequence":"additional","affiliation":[{"name":"Urology and Research, Connecticut Children\u2019s Medical Center, Hartford, Connecticut;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelleigh E.","family":"Briden","sequence":"additional","affiliation":[{"name":"Departments of Pediatric Surgery, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Neff","sequence":"additional","affiliation":[{"name":"Departments of Pediatric Surgery, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Ruscher","sequence":"additional","affiliation":[{"name":"Departments of Pediatric Surgery, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James I.","family":"Hagadorn","sequence":"additional","affiliation":[{"name":"Division of Neonatology, Connecticut Children's Medical Center, Hartford, Connecticut; and"},{"name":"Department of Pediatrics, University of Connecticut School of Medicine, Farmington, Connecticut"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2014,8,1]]},"reference":[{"key":"2021120903433761900_B1"},{"key":"2021120903433761900_B2","article-title":"Respiratory disorders in preterm and term infants","volume-title":"Fanaroff and Martin's Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant","author":"Abu-Shaweesh","year":"2011","edition":"9th ed."},{"issue":"9","key":"2021120903433761900_B3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/sj.jp.7211794","article-title":"Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies.","volume":"27","author":"Logan","year":"2007","journal-title":"J Perinatol"},{"issue":"9020","key":"2021120903433761900_B4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(96)04100-1","article-title":"UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation.","volume":"348","author":"UK Collaborative ECMO Trail Group","year":"1996","journal-title":"Lancet"},{"issue":"3","key":"2021120903433761900_B5","first-page":"CD001340","article-title":"Extracorporeal membrane oxygenation for severe respiratory failure in newborn infants.","author":"Mugford","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"2021120903433761900_B6","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.RES.61.6.866","article-title":"Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.","volume":"61","author":"Ignarro","year":"1987","journal-title":"Circ Res"},{"issue":"27","key":"2021120903433761900_B7","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","article-title":"The L-arginine-nitric oxide pathway.","volume":"329","author":"Moncada","year":"1993","journal-title":"N Engl J Med"},{"key":"2021120903433761900_B8","first-page":"133","article-title":"Inhaled nitric oxide: its effects on pulmonary circulation and airway smooth muscle cells.","volume":"14","author":"Rossaint","year":"1993","journal-title":"Eur Heart J"},{"issue":"8918","key":"2021120903433761900_B9","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(94)91341-2","article-title":"Echocardiographic investigation of inhaled nitric oxide in newborn babies with severe hypoxaemia.","volume":"344","author":"Roz\u00e9","year":"1994","journal-title":"Lancet"},{"issue":"7","key":"2021120903433761900_B10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1056\/NEJM200002173420704","article-title":"Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.","volume":"342","author":"Clark","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"2021120903433761900_B11","first-page":"CD000399","article-title":"Nitric oxide for respiratory failure in infants born at or near term.","author":"Finer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"issue":"9","key":"2021120903433761900_B12","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s004310050928","article-title":"Disease-related response to inhaled nitric oxide in newborns with severe hypoxaemic respiratory failure.","volume":"157","author":"Mercier","year":"1998","journal-title":"Eur J Pediatr"},{"issue":"9","key":"2021120903433761900_B13","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM199702273360901","article-title":"Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.","volume":"336","author":"Neonatal Inhaled Nitric Oxide Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"6","key":"2021120903433761900_B14","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1542\/peds.99.6.838","article-title":"Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia.","volume":"99","author":"The Neonatal Inhaled Nitric Oxide Study Group (NINOS)","year":"1997","journal-title":"Pediatrics"},{"key":"2021120903433761900_B15","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1038\/jp.2009.40","article-title":"Inhaled nitric oxide in the neonate.","volume":"29","author":"Soll","year":"2009","journal-title":"J Perinatol"},{"issue":"1","key":"2021120903433761900_B16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpedsurg.2010.09.060","article-title":"Protocolized management of infants with congenital diaphragmatic hernia: effect on survival.","volume":"46","author":"Antonoff","year":"2011","journal-title":"J Pediatr Surg"},{"issue":"4","key":"2021120903433761900_B17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000320622","article-title":"Standardized postnatal management of infants with congenital diaphragmatic hernia in Europe: the CDH EURO Consortium consensus.","volume":"98","author":"Reiss","year":"2010","journal-title":"Neonatology"},{"key":"2021120903433761900_B18","volume-title":"Hierarchical Linear Models: Applications and Data Analysis Methods","author":"Raudenbush","year":"2002","edition":"2nd ed."},{"issue":"2","key":"2021120903433761900_B19","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/j.sempedsurg.2007.01.008","article-title":"Pulmonary hypertension in congenital diaphragmatic hernia.","volume":"16","author":"Mohseni-Bod","year":"2007","journal-title":"Semin Pediatr Surg"},{"issue":"2","key":"2021120903433761900_B20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1053\/j.semperi.2005.04.008","article-title":"Pulmonary vasodilator therapy in congenital diaphragmatic hernia: acute, late, and chronic pulmonary hypertension.","volume":"29","author":"Kinsella","year":"2005","journal-title":"Semin Perinatol"},{"issue":"3","key":"2021120903433761900_B21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jpedsurg.2003.11.010","article-title":"The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia.","volume":"39","author":"Dillon","year":"2004","journal-title":"J Pediatr Surg"},{"issue":"8","key":"2021120903433761900_B22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/0022-3468(94)90269-0","article-title":"Inhaled nitric oxide in congenital diaphragmatic hernia.","volume":"29","author":"Shah","year":"1994","journal-title":"J Pediatr Surg"},{"issue":"5","key":"2021120903433761900_B23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1542\/peds.94.5.715","article-title":"Inhaled nitric oxide in congenital hypoplasia of the lungs due to diaphragmatic hernia or oligohydramnios.","volume":"94","author":"Karamanoukian","year":"1994","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903433761900_B24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1067\/mpd.2003.140","article-title":"Noninvasive delivery of inhaled nitric oxide therapy for late pulmonary hypertension in newborn infants with congenital diaphragmatic hernia.","volume":"142","author":"Kinsella","year":"2003","journal-title":"J Pediatr"},{"issue":"2","key":"2021120903433761900_B25","first-page":"25","article-title":"Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects\u2014United States, 2003.","volume":"56","author":"Centers for Disease Control and Prevention (CDC)","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2021120903433761900_B26","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-3566","article-title":"Medical and financial impact of a neonatal extracorporeal membrane oxygenation referral center in the nitric oxide era.","volume":"123","author":"Pawlik","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"2021120903433761900_B27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.jpedsurg.2010.09.047","article-title":"Costs of congenital diaphragmatic hernia repair in the United States\u2014extracorporeal membrane oxygenation foots the bill.","volume":"46","author":"Raval","year":"2011","journal-title":"J Pediatr Surg"},{"issue":"11","key":"2021120903433761900_B28","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-140-11-200406010-00011","article-title":"Creating the evidence base for quality improvement collaboratives.","volume":"140","author":"Mittman","year":"2004","journal-title":"Ann Intern Med"},{"key":"2021120903433761900_B29"},{"issue":"7659","key":"2021120903433761900_B30","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1136\/bmj.39570.749884.BE","article-title":"Evidence for the impact of quality improvement collaboratives: systematic review.","volume":"336","author":"Schouten","year":"2008","journal-title":"BMJ"},{"issue":"2","key":"2021120903433761900_B31","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1053\/j.sempedsurg.2008.02.004","article-title":"The Congenital Diaphragmatic Hernia Study Group: a voluntary international registry.","volume":"17","author":"Tsao","year":"2008","journal-title":"Semin Pediatr Surg"},{"issue":"3","key":"2021120903433761900_B32","article-title":"Defect size determines survival in infants with congenital diaphragmatic hernia.","volume":"120","author":"Lally","year":"2007","journal-title":"Pediatrics"},{"issue":"2","key":"2021120903433761900_B33","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1542\/peds.2008-0528","article-title":"Timing of delivery and survival rates for infants with prenatal diagnoses of congenital diaphragmatic hernia.","volume":"123","author":"Stevens","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"2021120903433761900_B34","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jpeds.2004.04.056","article-title":"Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia?","volume":"145","author":"Van Meurs","year":"2004","journal-title":"J Pediatr"},{"issue":"12","key":"2021120903433761900_B35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/jp.2012.18","article-title":"Does a highest pre-ductal O(2) saturation &lt;85% predict non-survival for congenital diaphragmatic hernia?","volume":"32","author":"Yoder","year":"2012","journal-title":"J Perinatol"},{"key":"2021120903433761900_B36"},{"issue":"4","key":"2021120903433761900_B37","first-page":"505","article-title":"Treatment evolution in high-risk congenital diaphragmatic hernia: ten years\u2019 experience with diaphragmatic agenesis.","volume":"244","author":"Lally","year":"2006","journal-title":"Ann Surg"},{"issue":"3","key":"2021120903433761900_B38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/00045391-200205000-00005","article-title":"Confounding by indication in epidemiologic studies of commonly used analgesics.","volume":"9","author":"Signorello","year":"2002","journal-title":"Am J Ther"},{"issue":"4","key":"2021120903433761900_B39","first-page":"335","article-title":"Confounding by indication.","volume":"7","author":"Walker","year":"1996","journal-title":"Epidemiology"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/e420\/1104015\/peds_2013-2644.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/2\/e420\/1104015\/peds_2013-2644.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,11]],"date-time":"2022-04-11T02:47:43Z","timestamp":1649645263000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/2\/e420\/32942\/Inhaled-Nitric-Oxide-Use-in-Neonates-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8,1]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,8,1]]},"published-print":{"date-parts":[[2014,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2013-2644","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,8,1]]}}}